A recent study found that women with a history of gestational diabetes who sleep less or snore regularly face a significantly higher risk of developing type 2 diabetes later in life.
Sleep health linked to type 2 diabetes risk in women with gestational diabetes | Image Credit: © StockPhotoPro - © StockPhotoPro - stock.adobe.com.
The risk of type 2 diabetes (T2D) is increased among women with gestational diabetes (GD) sleeping less and snoring occasionally or regularly, according to a recent study published in JAMA Network Open.1
According to the Centers for Disease Control and Prevention, 1 in 3 US adults sleep less than 7 hours per day. Sleep health has been linked to multiple adverse outcomes such as cancer, dementia, and potentially T2D. The risk of T2D is also increased among women with GD, which impacts 2% to 30% of pregnancies worldwide.2
“Women diagnosed with GD are nearly 10 times more likely to develop T2D later in life than those without a GD history,” wrote investigators.1 “Therefore, it is imperative to identify modifiable lifestyle factors related to the progression from GD to T2D.”
To evaluate the link between sleep characteristics and long-term T2D risk among women with GD, investigators conducted a cohort study. Women in the Nurses’ Health Study II (NHSII) with a history of GD were included in the analysis.
The NHSII included female nurses aged 24 to 44 years, recruited in 1989. Health-related behaviors and disease outcomes were obtained from self-reported questionnaires, including health status and lifestyle factors reported every 2 to 4 years.
Women with a history of GD reporting sleep characteristics in the NHSII 2001 questionnaire were included in the current analysis. Race and ethnicity data was also reported.
Sleep characteristics reported included how much participants slept per day and whether they snored. Snoring categories included almost never at 0 nights per week, occasionally at 1 to 2 nights per week, and regularly at 3 or more nights per week. Sleep duration categories included 6 or fewer, 7, 8, and 9 or more hours per day.
Daytime sleepiness was also reported, with categories including 0 days per week, 1 to 3 days per week, and at least 4 days per week. T2D data was collected through the biennial questionnaires and included symptoms, diagnostic tests, and hypoglycemic therapy.
Diabetes was confirmed through the presence of at least 1 American Diabetes Association criteria. Glycated hemoglobin (HbA1c), insulin, and C-peptide levels were measured as biomarkers of diabetes.
There were 2891 women with GD history aged a mean 45.3 years included in the analysis, 19.5% of whom reported T2D during follow-up. Of participants, 92.7% were White while 7.3% were other race or ethnicity.
Patients who snored regularly at baseline were more likely to smoke, have a respiratory illness, and use medications that impact sleep vs those who never snored. Those with shorter sleep durations were more often postmenopausal, night shift workers, or had a higher body mass index (BMI), caffeine intake, or depression.
A significant association was reported between snoring and T2D, with a hazard ratio (HR) of 2.17 for occasional snoring and 2.66 for regular snoring when compared to never snoring after adjusting for covariates. When further adjusting for BMI, these HRs were 1.54 and 1.61, respectively.
Sleeping for 6 hours or less per night was also significantly associated with future T2D vs sleeping for 7 or 8 hours, with an HR of 1.32. However, no link was reported between sleeping for 9 or more hours per night and T2D.
An HR of 1.50 was reported for T2D among women with daytime sleepiness 4 or more days per week vs those rarely or never experiencing daytime sleepiness. However, this association did not remain when adjusting for covariates beyond age.
Significantly increased HbA1c levels were reported among women snoring regularly vs those never snoring, at 5.89 vs 5.77, respectively. C-peptide and insulin levels were also increased among women snoring regularly. Overall, sleep duration and frequent snoring were linked to future T2D risk among women with a history of GD.
“These findings underscore the importance of sleep health, particularly for this high-risk population,” wrote investigators. “Prevention strategies for progression from GD to T2D should incorporate sleep health, emphasizing the monitoring of sleep duration and snoring.”
Reference
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
One-hour glucose tolerance test: Improved prediction of diabetes risk
March 4th 2025A new study finds that a 1-hour oral glucose tolerance test is more effective than the traditional 2-hour test in predicting future diabetes risk, especially for women with a history of gestational diabetes.
Read More